203 related articles for article (PubMed ID: 16477612)
1. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
Vanderlocht J; Hellings N; Hendriks JJ; Vandenabeele F; Moreels M; Buntinx M; Hoekstra D; Antel JP; Stinissen P
J Neurosci Res; 2006 Apr; 83(5):763-74. PubMed ID: 16477612
[TBL] [Abstract][Full Text] [Related]
2. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
[TBL] [Abstract][Full Text] [Related]
3. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of oligodendrocytes in multiple sclerosis.
Ruffini F; Chojnacki A; Weiss S; Antel JP
Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
[No Abstract] [Full Text] [Related]
5. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
Dhib-Jalbut S
Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of multiple sclerosis: status of research].
Hartung HP
Wien Med Wochenschr; 1996; 146(19-20):520-7. PubMed ID: 9082652
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
Henderson AP; Barnett MH; Parratt JD; Prineas JW
Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
[TBL] [Abstract][Full Text] [Related]
8. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
Taoufik E; Tseveleki V; Euagelidou M; Emmanouil M; Voulgari-Kokota A; Haralambous S; Probert L
Neurodegener Dis; 2008; 5(1):32-7. PubMed ID: 18075273
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3.
Slaets H; Dumont D; Vanderlocht J; Noben JP; Leprince P; Robben J; Hendriks J; Stinissen P; Hellings N
Proteomics; 2008 Mar; 8(6):1237-47. PubMed ID: 18338825
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
Marriott MP; Emery B; Cate HS; Binder MD; Kemper D; Wu Q; Kolbe S; Gordon IR; Wang H; Egan G; Murray S; Butzkueven H; Kilpatrick TJ
Glia; 2008 Apr; 56(6):686-98. PubMed ID: 18293407
[TBL] [Abstract][Full Text] [Related]
12. Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor.
Antel JP; Williams K; Blain M; McRea E; McLaurin J
Ann Neurol; 1994 Mar; 35(3):341-8. PubMed ID: 7510099
[TBL] [Abstract][Full Text] [Related]
13. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.
Aktas O; Smorodchenko A; Brocke S; Infante-Duarte C; Schulze Topphoff U; Vogt J; Prozorovski T; Meier S; Osmanova V; Pohl E; Bechmann I; Nitsch R; Zipp F
Neuron; 2005 May; 46(3):421-32. PubMed ID: 15882642
[TBL] [Abstract][Full Text] [Related]
14. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis.
van Noort JM; van Sechel AC; Bajramovic JJ; el Ouagmiri M; Polman CH; Lassmann H; Ravid R
Nature; 1995 Jun; 375(6534):798-801. PubMed ID: 7596414
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes.
Schulte-Herbrüggen O; Nassenstein C; Lommatzsch M; Quarcoo D; Renz H; Braun A
J Neuroimmunol; 2005 Mar; 160(1-2):204-9. PubMed ID: 15710474
[TBL] [Abstract][Full Text] [Related]
16. Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages.
Hendriks JJ; Slaets H; Carmans S; de Vries HE; Dijkstra CD; Stinissen P; Hellings N
J Neuroimmunol; 2008 Nov; 204(1-2):52-7. PubMed ID: 18771807
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.
Martino G; Grohovaz F; Brambilla E; Codazzi F; Consiglio A; Clementi E; Filippi M; Comi G; Grimaldi LM
Ann Neurol; 1998 Mar; 43(3):340-9. PubMed ID: 9506551
[TBL] [Abstract][Full Text] [Related]
18. Cytokine toxicity to oligodendrocyte precursors is mediated by iron.
Zhang X; Haaf M; Todorich B; Grosstephan E; Schieremberg H; Surguladze N; Connor JR
Glia; 2005 Nov; 52(3):199-208. PubMed ID: 15968631
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid enhances leukemia inhibitory factor expression in OLN-93 oligodendrocytes.
Mey J; Henkes L
Cell Tissue Res; 2002 Nov; 310(2):155-61. PubMed ID: 12397370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
